GLP-1 drugs represent a new class of treatment for managing diabetes and, increasingly, body reduction. Tirzepatid, Semagglutide, and the newer substance Retatrutide are prominent instances within this group. These agents work by mimicking the body's natural GLP-1 substance, stimulating glucose production and suppressing glucagon secretion, ultimat